LEVI, SONIA MARIA ROSA
 Distribuzione geografica
Continente #
NA - Nord America 3.567
EU - Europa 3.414
AS - Asia 3.214
SA - Sud America 750
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 62
OC - Oceania 3
Totale 11.113
Nazione #
US - Stati Uniti d'America 3.356
RU - Federazione Russa 1.951
CN - Cina 1.174
SG - Singapore 1.150
BR - Brasile 626
SE - Svezia 521
IT - Italia 424
HK - Hong Kong 380
VN - Vietnam 246
FR - Francia 160
CA - Canada 100
DE - Germania 88
GB - Regno Unito 79
IN - India 65
AR - Argentina 53
BD - Bangladesh 47
FI - Finlandia 41
MX - Messico 35
EC - Ecuador 27
ZA - Sudafrica 27
AT - Austria 24
PL - Polonia 23
CR - Costa Rica 21
IQ - Iraq 21
IE - Irlanda 20
TR - Turchia 20
ES - Italia 19
ID - Indonesia 19
JP - Giappone 16
NL - Olanda 14
CO - Colombia 13
MA - Marocco 13
JM - Giamaica 12
UA - Ucraina 12
RO - Romania 11
HN - Honduras 9
UZ - Uzbekistan 8
LT - Lituania 7
PK - Pakistan 7
TT - Trinidad e Tobago 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
PH - Filippine 6
PY - Paraguay 6
UY - Uruguay 6
CL - Cile 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
KE - Kenya 5
NI - Nicaragua 5
PE - Perù 5
SA - Arabia Saudita 5
KZ - Kazakistan 4
NP - Nepal 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
LB - Libano 3
QA - Qatar 3
SV - El Salvador 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
RW - Ruanda 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
PS - Palestinian Territory 1
Totale 11.011
Città #
Ashburn 627
Singapore 474
Moscow 451
San Jose 416
Hong Kong 371
Dallas 293
New York 252
Shanghai 215
Council Bluffs 192
Hefei 164
Lawrence 154
Princeton 154
Milan 142
Lauterbourg 136
Beijing 103
Ho Chi Minh City 92
Hanoi 57
Los Angeles 50
Phoenix 50
Santa Clara 47
São Paulo 42
Washington 37
Miano 36
Helsinki 29
Pune 29
Rio de Janeiro 27
Houston 25
North Bergen 23
Orem 23
Brooklyn 22
Montreal 22
Warsaw 20
Boardman 18
Toronto 18
Atlanta 17
Chicago 17
Denver 16
Dublin 16
Johannesburg 16
San José 16
Belo Horizonte 15
Chennai 15
Tokyo 15
Brasília 14
Guangzhou 14
Nuremberg 13
Rome 13
Stockholm 13
Barnet 12
The Dalles 12
Tianjin 12
Baghdad 11
Campinas 11
Curitiba 11
London 11
Poplar 11
Porto Alegre 11
Vienna 11
Ankara 10
Da Nang 10
Guayaquil 10
Guarulhos 9
Louisville 9
Quito 9
San Francisco 9
Seattle 9
Columbus 8
Kingston 8
Lappeenranta 8
Manchester 8
Betim 7
Jacksonville 7
Miami 7
Naples 7
Xi'an 7
Boston 6
Brescia 6
Caxias do Sul 6
Dhaka 6
Frankfurt am Main 6
Haiphong 6
Mexico City 6
Milwaukee 6
Mumbai 6
Munich 6
Newark 6
Ribeirão Preto 6
Salvador 6
Shenzhen 6
Sissa 6
Tashkent 6
Wuxi 6
Blumenau 5
Buenos Aires 5
Buffalo 5
Cape Town 5
Carapicuíba 5
Carrboro 5
Juiz de Fora 5
Las Vegas 5
Totale 5.418
Nome #
A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits 132
An approach for screening of Hereditary Hyperferritinemia Cataract Syndrome (HHCS) by a new DG-DGGE method for rapid mutational scanning in ferritin L-chain IRE. 131
Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions 113
Mitochondrial iron deficiency triggers cytosolic iron overload in PKAN hiPS-derived astrocytes 110
C29G in the iron-responsive element of L-ferritin: a new mutation associated with hyperferritinemia-cataract 108
ANIMAL MODELS OF NEUROFERRITINOPATHY 108
Analysis of ferritin genes in Parkinson disease. 105
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins 103
A new G51C mutation in the IRE of L-ferritin in hyperferritinemia cataract syndrome decreases the binding affinity of the mutant IRE to IRP. 101
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes. 99
Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism 99
Identification of the ferroxidase centre in ferritin. 96
Iron pathophysiology in neurodegeneration with brain iron accumulation 93
CoA synthase plays a critical role in neurodevelopment and neurodegeneration 92
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 91
Blotting Analysis of Native IRP1: A Novel Approach to Distinguish the Different Forms of IRP1 in Cells and Tissues 90
Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype 90
A new mutation in the IRE of L-ferritin (G51C) associated with hyperferritinemia-cataract syndrome decreases the binding affinity of IRE to IRPS 88
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome 88
Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation. 88
Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome 86
A human mitochondrial ferritin encoded by an intronless gene 86
H-ferritin receptors, intracellular H-ferritin and tumor necrosis factor alpha in activated THP-1 myielomonocytic cells. 86
Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins 86
Actions of H-subunit ferritin and lactoferrin as suppressor molecules of myelopoiesis in vitro and in vivo. 85
CHARACTERIZATION OF THE L-FERRITIN VARIANT 460INSA RESPONSIBLE OF A HEREDITARY FERRITINOPATHY DISORDER 85
Mitochondrial Ferritin is a HIF1α-Inducible Gene that Protects from Hypoxia-Induced Cell Death in Brain 83
Case report: a subject with a mutation in the ATG start codon of L-ferritin has no hematological or neurological symptoms 82
Analysis of the iron status of professional cyclists during a 3-week road race. 82
MUTATED RECOMBINANT HUMAN HEAVY-CHAIN FERRITINS AND MYELOSUPPRESSION INVITRO AND INVIVO - A LINK BETWEEN FERRITIN FERROXIDASE ACTIVITY AND BIOLOGICAL FUNCTION 81
Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin 81
BINDING AND SUPPRESSIVE ACTIVITY OF HUMAN RECOMBINANT FERRITINS ON ERYTHROID-CELLS 80
H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis. 79
Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging 79
The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload 78
The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins 78
A mutational analysis of the epitopes of recombinant human H-ferritin. 78
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype 77
Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model 77
Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells 75
Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy 75
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation 75
ANTIBODIES FOR DENATURED HUMAN H-FERRITIN STAIN ONLY RETICULOENDOTHELIAL CELLS WITHIN THE BONE-MARROW 74
Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells. 73
Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors. 73
Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. 73
Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition 73
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) 72
EVIDENCE THAT A SALT BRIDGE IN THE LIGHT CHAIN CONTRIBUTES TO THE PHYSICAL STABILITY DIFFERENCE BETWEEN HEAVY AND LIGHT HUMAN FERRITINS 72
Characterization of human ferritin H chain synthetized in Escherichia coli. 72
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts 71
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage 71
The role of iron in mitochondrial function 71
FERROXIDASE KINETICS OF HUMAN LIVER APOFERRITIN, RECOMBINANT H-CHAIN APOFERRITIN, AND SITE-DIRECTED MUTANTS 70
Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide. 70
Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome. 70
Iron detoxifying activity of ferritin. Effects of H and L human apoferritins on lipid peroxidation in vitro. 70
Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferro-oxidase site. A study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. 70
Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells. 69
Iron imbalance in neurodegeneration 68
Iron oxidation in sheep, horse and recombinant human apoferritins. 68
Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients. 68
Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia 68
The influence of purified recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. 68
Study of FTMT and ABCA4 genes in a patient affected by age-related macular degeneration: identification and analysis of new mutations. 68
DEFECTIVE TARGETING OF HEMOJUVELIN TO PLASMA MEMBRANE IS A COMMON PATHOGENETIC MECHANISM IN JUVENILE HEMOCHROMATOSIS 67
Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism. 67
HUMAN FERRITIN H-CHAINS CAN BE OBTAINED IN NONASSEMBLED STABLE FORMS WHICH HAVE FERROXIDASE ACTIVITY 67
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells 67
Relation of Cytosolic Iron Excess to Cardiomyopathy of Friedreich's Ataxia. 67
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. 67
Unexplained isolated hyperferritinemia without iron overload 66
Mutational analysis of the channel and loop sequences of human ferritin H-chain. 66
Crystallographic data for horse heart ferritin 65
Early embryonic lethality of H ferritin gene deletion in mice 65
Characteristics of a ferritin-binding protein present in human serum. 65
Serum ferritin in type I diabetes. 65
INFLUENCE OF SITE-DIRECTED MODIFICATIONS ON THE FORMATION OF IRON CORES IN FERRITIN 65
Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. 65
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis 64
Characteristics of ferritins in human milk secretions: similarities to serum and tissue isoferritins. 64
Transient overexpression of human H- and L-ferritin chains in COS cells 64
The pathogenesis of cardiomyopathy in Friedreich ataxia. 64
Defining metal ion inhibitor interactions with recombinant human H- and L-chain ferritins and site-directed variants: an isothermal titration calorimetry study 64
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 64
Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. FEBS Lett. 2003 Feb 27;537(1-3):187-92 64
Ferritin in Malignant Cells 63
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. 63
Unique Iron Binding and Oxidation Properties of Human Mitochondrial Ferritin: A Comparative Analysis with Human H-chain Ferritin 63
The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs 63
Multiple pathways for mineral core formation in mammalian apoferritin. The role of hydrogen peroxide 62
Chemico-physical and functional differences between H and L chains of human ferritin. 62
Ferritins in malignant and non-malignant lymphoid cells. 62
Identification of two novel mutations in the 5 ' untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning 62
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers 62
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein 62
Spermatozoa mitochondrial ferritin (MtF) content is related to sperm motility. 62
SPECIFIC BINDING-SITES FOR H-FERRITIN ON HUMAN-LYMPHOCYTES - MODULATION DURING CELLULAR PROLIFERATION AND POTENTIAL IMPLICATION IN CELL-GROWTH CONTROL 62
Mutant ferritin L-chains that cause neurodegeneration act in a dominant-negative manner to reduce ferritin iron incorporation 62
H-FERRITINS AND L-FERRITINS IN MYOCARDIUM IN IRON OVERLOAD 62
Totale 7.665
Categoria #
all - tutte 77.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 0 0 45 9 3 3 6 5 5 1 24
2022/2023858 349 195 78 2 1 102 18 59 40 1 10 3
2023/2024632 5 0 29 103 48 282 14 40 1 17 19 74
2024/20251.879 232 23 46 77 48 146 250 163 328 275 129 162
2025/20266.069 456 456 399 845 415 167 588 410 1.817 319 82 115
2026/20271.512 123 423 359 607 0 0 0 0 0 0 0 0
Totale 11.113